Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Patterns of Sleep Restriction and Recovery: The Inflammatory Resolution Pathways
NCT03377543Phase 1Active, not recruiting
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- Jun 2018
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised trial in inflammation comparing Control Sleep/Non-Active Placebo or 81mg Aspirin Pill, Sleep Restriction/81mg Aspirin Pill and Sleep Restriction/Non-Active Placebo (3 arms). Primary endpoint: Inflammatory Resolution Markers. Started Jun 2018; status: active, not recruiting.
02
Drugs
aspirin
03
Conditions
inflammation
Beyond the preview
Go deeper on NCT03377543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03377543.